Guo‐Xiang Hao
Shandong University(CN)Equibreed (New Zealand)(NZ)
Publications by Year
Research Areas
Antibiotics Pharmacokinetics and Efficacy, Pharmaceutical studies and practices, Pneumonia and Respiratory Infections, Antibiotic Resistance in Bacteria, Pharmacogenetics and Drug Metabolism
Most-Cited Works
- → Drug Clearance in Neonates: A Combination of Population Pharmacokinetic Modelling and Machine Learning Approaches to Improve Individual Prediction(2021)46 cited
- → Machine Learning: A New Approach for Dose Individualization(2023)44 cited
- → Use of Machine Learning for Dosage Individualization of Vancomycin in Neonates(2023)29 cited
- → Population pharmacokinetics of tacrolimus in children with nephrotic syndrome(2018)29 cited
- → Developmental Population Pharmacokinetics and Dosing Optimization of Cefepime in Neonates and Young Infants(2020)27 cited
- → A first-in-human phase 1 study of simnotrelvir, a 3CL-like protease inhibitor for treatment of COVID-19, in healthy adult subjects(2023)24 cited
- → Precision therapy of 6‐mercaptopurine in Chinese children with acute lymphoblastic leukaemia(2020)19 cited
- → Population pharmacokinetics and dosing optimization of metformin in Chinese patients with type 2 diabetes mellitus(2020)18 cited
- → Off-label use of tacrolimus in children with Henoch-Schönlein purpura nephritis: a pilot study(2018)18 cited
- → Determination of cefoperazone and sulbactam in serum by HPLC‐MS/MS: An adapted method for therapeutic drug monitoring in children(2017)15 cited